Publication | Closed Access
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
51
Citations
29
References
2012
Year
In this retrospective observational multicentre study, rosuvastatin 5 mg was found to be safe and biochemically effective either as daily or intermittent therapy in patients intolerant to other conventional statin regimens.
| Year | Citations | |
|---|---|---|
Page 1
Page 1